TScan Therapeutics
TCRX
TCRX
80 hedge funds and large institutions have $51.8M invested in TScan Therapeutics in 2025 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 26 increasing their positions, 18 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
38% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 32
Holders
80
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$3.63M | |
| 2 | +$902K | |
| 3 | +$578K | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$488K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$402K |
Top Sellers
| 1 | -$4.83M | |
| 2 | -$3.35M | |
| 3 | -$2.78M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$915K |
| 5 |
State Street
Boston,
Massachusetts
|
-$894K |
